DEBBIE TANEDO: Open Payments
NPI 1598170862 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$636 in 27 payments from 14 companies in 2025. Trend: 2023 $198 · 2024 $404 · 2025 $636
Food & beverage: $636
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $95 |
| Janssen Pharmaceuticals, Inc | 2 | $79 |
| Lilly USA, LLC | 3 | $75 |
| Exact Sciences Corporation | 3 | $68 |
| Novartis Pharmaceuticals Corporation | 3 | $66 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Amgen Inc. | 2 | $41 |
| ViiV Healthcare Company | 1 | $34 |
| Dexcom, Inc. | 1 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: SPRAVATO, Wegovy, MOUNJARO, LEQVIO, INJECTAFER, APRETUDE, Dexcom G6 Transmitter, Veozah.
Industry payments across CA — which companies pay providers there.
